SOCS3 and hepatocellular carcinoma: Consistent with our previous finding [32], the expression of SOCS3 was upregulated by E2 and ERβ agonist DPN but not by ERα agonist PPT (Figure 6(b)), suggesting that estrogenic SOCS-mediated effect against HCC growth is primarily via ERβ.